Scott Eggener to Thiohydantoins
This is a "connection" page, showing publications Scott Eggener has written about Thiohydantoins.
Connection Strength
0.060
-
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial. Clin Cancer Res. 2026 Feb 04; 32(3):479-488.
Score: 0.060